Nancy Mohammad
Research Subjects
Research Interests
Nancy Mohammad has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Sallam Soliman
Clinical pathology departement,faculty of medicine ,zagazig university, Egypt
1 shared publication- Alaa A. Farag
Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication - Amany Mohyeldin Sediq
Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication Amira Ahmed Mahmoud
Internal Medicine departement, faculty of medicine , Zagazig University ,Egypt
1 shared publication- Elsayed Saad Abd Elbaser
Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication - Hanan Hasan Soliman
Department of Public Health Community, Environmental and Occupational Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
1 shared publication
Latest Publications
- 31 December 2021
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
THE RELATIONSHIP BETWEEN HIGH SENSITIVE C- REACTIVE PROTEIN,INTERLEUKIN-6 , TUMOR NECROSIS FACTORS -α AND COGNITIVE FUNCTION IN ELDERLY DIABETICS IN ZAGAZIG UNIVERSITY HOSPITALS
Many reaserches have shown associations between inflammatory markers and the risk of cognitive functions decline. Higher serum levels of CRP,IL-6 and TNF-α are associated with deteriorating cognitive function in elderly. The goal of this reaserch was to detect cognitive impairment in elderly individuals with diabetes and their relation to hs-CRP,IL-6 and TNF-α in those individuals. Two hundred fifty-five elderly individuals which were divided into 3 groups according to present or absence of diabetes together with level of diabetes control; Group I: 85 elderly individuals without diabetes, Group II: 85 elderly patients with controlled diabetes. Group III: 85 elderly patients with uncontrolled diabetes. Routine laboratory investigations together with lipid profile , hs- CRP,IL-6 and TNF-α were analyzed in three groups using blood serum sample then correlated to degree of cognitive impairment using mini mental state examination (MMSE). The present study proved that a statistical significant negative correlation between hs-CRP and MMS score examination in total population was found , there is statistical significant negative correlation between hs-CRP ,IL-6 ,TNF-α and MMS score examination in total elderly subjects with diabetes.. As well, there is significant positive correlation between hs-CRP and parameters of diabetic control So, estimation of inflammatory markers in elderly patients with diabetes may be a reliable indicator to identify and anticipate cognitive dysfunction in such individuals.KEYWORDS: hs-CRP,IL-6, TNF-α , cognitive function, elderly diabetics
- 31 December 2021
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
THE RELATIONSHIP BETWEEN HIGH SENSITIVE C- REACTIVE PROTEIN,INTERLEUKIN-6 , TUMOR NECROSIS FACTORS -α AND COGNITIVE FUNCTION IN ELDERLY DIABETICS IN ZAGAZIG UNIVERSITY HOSPITALS
Many reaserches have shown associations between inflammatory markers and the risk of cognitive functions decline. Higher serum levels of CRP,IL-6 and TNF-α are associated with deteriorating cognitive function in elderly. The goal of this reaserch was to detect cognitive impairment in elderly individuals with diabetes and their relation to hs-CRP,IL-6 and TNF-α in those individuals. Two hundred fifty-five elderly individuals which were divided into 3 groups according to present or absence of diabetes together with level of diabetes control; Group I: 85 elderly individuals without diabetes, Group II: 85 elderly patients with controlled diabetes. Group III: 85 elderly patients with uncontrolled diabetes. Routine laboratory investigations together with lipid profile , hs- CRP,IL-6 and TNF-α were analyzed in three groups using blood serum sample then correlated to degree of cognitive impairment using mini mental state examination (MMSE). The present study proved that a statistical significant negative correlation between hs-CRP and MMS score examination in total population was found , there is statistical significant negative correlation between hs-CRP ,IL-6 ,TNF-α and MMS score examination in total elderly subjects with diabetes.. As well, there is significant positive correlation between hs-CRP and parameters of diabetic control So, estimation of inflammatory markers in elderly patients with diabetes may be a reliable indicator to identify and anticipate cognitive dysfunction in such individuals.KEYWORDS: hs-CRP,IL-6, TNF-α , cognitive function, elderly diabetics
- Open Access
- 2 August 2021
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 6 (3) , 142
Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and its associated morbidities. The goal of this study was to determine the frequency of newly diagnosed diabetes mellitus (DM) and its different types among COVID-19 patients, and to check the glycemic control in diabetic cases for three months. After excluding known cases of DM, 570 patients with confirmed COVID-19 were studied. All participants were classified as non-diabetic or newly discovered diabetic. According to hemoglobin A1c (HbA1c) and fasting insulin, newly discovered diabetic patients were further classified into pre-existing DM, new-onset type 1 DM, and new-onset type 2 DM. Glycemic control was monitored for three months in newly diagnosed diabetic patients. DM was diagnosed in 77 patients (13.5%); 12 (2.1%) with pre-existing DM, 7 (1.2%) with new-onset type 1 DM, and 58 (10.2%) with new-onset type 2 DM. Significantly higher rates of severe infection and mortality (p < 0.001 and p = 0.046) were evident among diabetic patients. Among survived diabetic patients (n = 63), hyperglycemia and the need for anti-diabetic treatment persisted in 73% of them for three months. COVID-19 was associated with a new-onset of DM in 11.4% of all participants and expression of pre-existing DM in 2.1% of all participants, both being associated with severe infection. COVID-19 patients with newly diagnosed diabetes had high risk of mortality. New-onset DM persisted for at least three months in more than two-thirds of cases.
- 2 August 2021
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 6 (3) , 142
Open AccessNewly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and its associated morbidities. The goal of this study was to determine the frequency of newly diagnosed diabetes mellitus (DM) and its different types among COVID-19 patients, and to check the glycemic control in diabetic cases for three months. After excluding known cases of DM, 570 patients with confirmed COVID-19 were studied. All participants were classified as non-diabetic or newly discovered diabetic. According to hemoglobin A1c (HbA1c) and fasting insulin, newly discovered diabetic patients were further classified into pre-existing DM, new-onset type 1 DM, and new-onset type 2 DM. Glycemic control was monitored for three months in newly diagnosed diabetic patients. DM was diagnosed in 77 patients (13.5%); 12 (2.1%) with pre-existing DM, 7 (1.2%) with new-onset type 1 DM, and 58 (10.2%) with new-onset type 2 DM. Significantly higher rates of severe infection and mortality (p < 0.001 and p = 0.046) were evident among diabetic patients. Among survived diabetic patients (n = 63), hyperglycemia and the need for anti-diabetic treatment persisted in 73% of them for three months. COVID-19 was associated with a new-onset of DM in 11.4% of all participants and expression of pre-existing DM in 2.1% of all participants, both being associated with severe infection. COVID-19 patients with newly diagnosed diabetes had high risk of mortality. New-onset DM persisted for at least three months in more than two-thirds of cases.